Difficulty: Medium
Average Score: 88%
Practice
Anticholinergic effects like dry mouth and constipation are commonly observed with all of the following drug classes except
Correct answer
B
Rationale
The correct answer is B) 2nd generation H1 antagonists because they are designed to have less affinity for the cholinergic receptors, thus reducing the likelihood of causing anticholinergic effects like dry mouth and constipation.
1st generation H1 antagonists (Option A) such as diphenhydramine commonly cause anticholinergic effects due to their ability to cross the blood-brain barrier and affect central cholinergic receptors. Intranasal antihistamines (Option C) like azelastine can also lead to anticholinergic effects due to their systemic absorption.
Gamma-3 muscarinic receptor agonists (Option D) would not cause anticholinergic effects as they are designed to activate muscarinic receptors, which is opposite to the mechanism of anticholinergic drugs.
In an educational context, understanding the differences in drug classes and their potential side effects is crucial for healthcare professionals to make informed decisions when prescribing medications, especially in vulnerable populations such as the elderly where anticholinergic effects can have significant implications on health and quality of life.
1st generation H1 antagonists (Option A) such as diphenhydramine commonly cause anticholinergic effects due to their ability to cross the blood-brain barrier and affect central cholinergic receptors. Intranasal antihistamines (Option C) like azelastine can also lead to anticholinergic effects due to their systemic absorption.
Gamma-3 muscarinic receptor agonists (Option D) would not cause anticholinergic effects as they are designed to activate muscarinic receptors, which is opposite to the mechanism of anticholinergic drugs.
In an educational context, understanding the differences in drug classes and their potential side effects is crucial for healthcare professionals to make informed decisions when prescribing medications, especially in vulnerable populations such as the elderly where anticholinergic effects can have significant implications on health and quality of life.